Rescue of Alzheimer’s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells

Alzheimer’s disease (AD) is the most prevalent cause of dementia; microglia have been implicated in AD pathogenesis, but their role is still matter of debate. Our study showed that single systemic wild-type (WT) hematopoietic stem and progenitor cell (HSPC) transplantation rescued the AD phenotype i...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 42; no. 8; p. 112956
Main Authors Mishra, Priyanka, Silva, Alexander, Sharma, Jay, Nguyen, Jacqueline, Pizzo, Donald P., Hinz, Denise, Sahoo, Debashis, Cherqui, Stephanie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 29.08.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer’s disease (AD) is the most prevalent cause of dementia; microglia have been implicated in AD pathogenesis, but their role is still matter of debate. Our study showed that single systemic wild-type (WT) hematopoietic stem and progenitor cell (HSPC) transplantation rescued the AD phenotype in 5xFAD mice and that transplantation may prevent microglia activation. Indeed, complete prevention of memory loss and neurocognitive impairment and decrease of β-amyloid plaques in the hippocampus and cortex were observed in the WT HSPC-transplanted 5xFAD mice compared with untreated 5xFAD mice and with mice transplanted with 5xFAD HSPCs. Neuroinflammation was also significantly reduced. Transcriptomic analysis revealed a significant decrease in gene expression related to “disease-associated microglia” in the cortex and “neurodegeneration-associated endothelial cells” in the hippocampus of the WT HSPC-transplanted 5xFAD mice compared with diseased controls. This work shows that HSPC transplant has the potential to prevent AD-associated complications and represents a promising therapeutic avenue for this disease. [Display omitted] •WT HSPC transplantation rescues memory and neurocognitive decline•WT HSPC transplantation reduces Aβ plaque density and partially preserves blood-brain integrity•WT HSPC transplantation may prevent microgliosis and neuroinflammation Mishra et al. demonstrate that single systemic wild-type hematopoietic stem and progenitor cell transplantation leads to complete preservation of the neurocognitive performance, partial preservation of blood-brain barrier integrity, and reduction of the Aβ plaque, microgliosis, and neuroinflammation in 5xFAD mice. In contrast, 5xFAD HSPC transplantation has no to limited impact.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AUTHOR CONTRIBUTIONS
S.C. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conceptualization and design, S.C. and P.M.; acquisition, analysis, or interpretation of data, S.C., P.M., A.S., D.S., and D.H.; drafting of the manuscript, S.C., P.M., and A.S.; critical revision of the manuscript for important intellectual content, all authors; statistical analysis, P.M., A.S., and D.S.; obtained funding, S.C.; technical or material support, A.S., J.S., J.N., D.P.P., and D.H.; supervision, S.C.; and S.C. made the final decision to submit the manuscript to Cell Reports for publication.
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2023.112956